PT  - JOURNAL ARTICLE
AU  - Doyon, Anke
AU  - Hofstetter, Jonas
AU  - Bayazit, Aysun Karabay
AU  - Azukaitis, Karolis
AU  - Niemirska, Ana
AU  - Civilibal, Mahmut
AU  - Kaplan Bulut, Ipek
AU  - Duzova, Ali
AU  - Oguz, Berna
AU  - Ranchin, Bruno
AU  - Shroff, Rukshana
AU  - Bilginer, Yelda
AU  - Caliskan, Salim
AU  - Paripovic, Dusan
AU  - Candan, Cengiz
AU  - Yilmaz, Alev
AU  - Harambat, Jerome
AU  - Özçakar, Z. Birsin
AU  - Lugani, Francesca
AU  - Alpay, Harika
AU  - Tschumi, Sibylle
AU  - Yilmaz, Ebru
AU  - Drozdz, Dorota
AU  - Tabel, Yilmaz
AU  - Özcelik, Gül
AU  - Caldas Afonso, Alberto
AU  - Yavascan, Onder
AU  - Melk, Anette
AU  - Querfeld, Uwe
AU  - Schaefer, Franz
AU  - ,
TI  - Progression of Carotid Intima-Media Thickness in Children of the Cardiovascular Comorbidity in Children with Chronic Kidney Disease Study (4C Study) – Risk Factors and Impact of Blood Pressure Dynamics
AID  - 10.1101/2024.07.13.24310158
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.13.24310158
4099  - http://medrxiv.org/content/early/2024/07/14/2024.07.13.24310158.short
4100  - http://medrxiv.org/content/early/2024/07/14/2024.07.13.24310158.full
AB  - Rationale The progression of cardiovascular disease (CVD) in children with chronic kidney disease (CKD) is not well understood.Objective To investigate carotid intima-media thickness (cIMT) as a surrogate marker for CVD in 670 patients of the 4C Study (The Cardiovascular Comorbidity in Children with CKD Study), aged 6 - 17 years, with CKD stage 3-5 at baseline. Patients were observed for a period of up to 8 years.Methods and Results A linear mixed model was employed to analyse the longitudinal course of cIMT standard deviation score (SDS) and associated clinical risk factors. The association between cIMT SDS change rate and systolic and diastolic BP SDS change rate per year was investigated. cIMT SDS increased significantly during the prospective observation period, with the slope of increase attenuating over time. Younger, taller and female patients were at an elevated risk for elevated cIMT SDS. Further risk factors included diastolic blood pressure and serum albumin for all patients, albuminuria in progressive CKD, and serum phosphate in stable CKD. Diastolic blood pressure SDS decreased and its effect on cIMT SDS attenuated over time. The yearly diastolic and systolic blood pressure change rates were associated with the cIMT SDS change rate within the first 4.5 years. This indicates a progressive change in cIMT with increasing blood pressure over time, and a decrease in cIMT with lowering of blood pressure.Conclusions The results demonstrate a progressive increase in cIMT over time in children with CKD, with traditional risk factors such as albuminuria, serum phosphate and blood pressure as relevant predictive factors for cIMT SDS. The association of cIMT SDS progression with blood pressure dynamics suggests potential benefits of blood pressure control in children with CKD. Our findings indicate that cIMT may serve as a surrogate parameter for future clinical trials in children.Competing Interest StatementThe authors have declared no competing interest.Funding Statementthe ERA-EDTA Research Programme, the KfH Foundation for Preventive Medicine and the German Federal Ministry of Education and Research (01EO0802)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of Heidelberg University (S-032/2009) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsCVDCardiovascular DiseaseCKDChronic Kidney Disease4CStudy the Cardiovascular Comorbidity in Children with CKD study cIMT Carotid Intima-media ThicknessESKDEnd-stage Kidney DiseasePWVPulse Wave VelocityKRTKidney Replacement TherapySDSStandard Deviation ScoreiPTHintact Parathyroid HormoneCRPC-reactive ProteineGFRestimated Glomerular Filtration RateBPBlood PressureWHOWorld Health OrganizationSDStandard DeviationLMMLinear Mixed ModelP-CKDProgressive Kidney DiseaseS-CKDStable Chronic Kidney DiseaseAKIAcute Kidney InjuryIPCIntra-patient Correlationsδ systolic BP SDSyearly change rate of systolic BP SDSδ diastolic BP SDSyearly change rate of diastolic BP SDS